Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of …
MarketWatch MENLO PARK, Calif., May 26, 2015 /PRNewswire/ — Asterias Biotherapeutics, Inc. (nyse mkt:AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that all outstanding common share purchase warrants … |